Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010

@silke4senate @laurenahan1 @NBCCStopBC https://t.co/oFgFsi4v4l

@rebeccazom @ihatebreastcanc also lumping stage 1-3 is really distorting because the risk is quite a bit greater with each stage https://t.co/NVbyVVi9jV https://t.co/TEYtbTOc2I

@abcdiagnosis https://t.co/CD0nuCpGR2

@JaniceC8957 Best resource. German cancer registry data shows the same picture. https://t.co/PF9a0RMdbT

@ESchattner @hoperugo @NEJM Malmgren et al. https://t.co/te4ZgHL7V2 German registry data (they count rMBC) shows same results. De novo MBC showed 2 year longer median survival since 90, however, per a SEER analysis, they still die two years younger than rM

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010 https://t.co/4Rda8A36Y2

Have you read this? https://t.co/PF9a0S3OAt

https://t.co/PF9a0S3OAt

@ESchattner I can't recall if you've written about this study, but it is a shame that all the individual success stories of drugs don't seem to add up to life expectancy of #rMBC patients! https://t.co/PF9a0S3OAt https://t.co/Lnm71REzHc

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010. https://t.co/919bBF8pZH?